Pharmacokinetic Study of ASP015K - Evaluation of Pharmacokinetics in Patients With Impaired Hepatic Function and Subjects With Normal Hepatic Function
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2016
At a glance
- Drugs Peficitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Astellas Pharma
- 05 Oct 2016 Status changed from recruiting to completed.
- 23 Feb 2016 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 29 Oct 2015 New trial record